Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact? An NRG Oncology/Gynecologic Oncology Group study ancillary study.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact? An NRG Oncology/Gynecologic Oncology Group study ancillary study.
Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact? An NRG Oncology/Gynecologic Oncology Group study ancillary study. Gynecol Oncol. 2016 Dec; 143(3):484-489.
View in:
PubMed
subject areas
Adenocarcinoma, Clear Cell
Adenocarcinoma, Clear Cell
Aged
Aged
Antineoplastic Agents
Antineoplastic Agents
Carcinoma, Endometrioid
Carcinoma, Endometrioid
Chemotherapy, Adjuvant
Chemotherapy, Adjuvant
Cytoreduction Surgical Procedures
Cytoreduction Surgical Procedures
Disease-Free Survival
Disease-Free Survival
Female
Female
Humans
Humans
Infusions, Parenteral
Infusions, Parenteral
Middle Aged
Middle Aged
Neoplasm Staging
Neoplasm Staging
Neoplasm, Residual
Neoplasm, Residual
Neoplasms, Cystic, Mucinous, and Serous
Neoplasms, Cystic, Mucinous, and Serous
Neoplasms, Glandular and Epithelial
Neoplasms, Glandular and Epithelial
Ovarian Neoplasms
Ovarian Neoplasms
Paclitaxel
Paclitaxel
Prognosis
Prognosis
Proportional Hazards Models
Proportional Hazards Models
Retrospective Studies
Retrospective Studies
Survival Rate
Survival Rate
Time Factors
Time Factors
authors with profiles
Joan L Walker